Clinical Trial Update: A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating inhaled dry powder mannitol for safety and efficacy in cystic fibrosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Bronchitol (mannitol) (mannitol)

Snippet

Sponsor: Syntara | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED